The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
There are also a lot of PI's on the reddit forum with 100k+ shares and some 1m+.
This is no ordinary AIM 'make a quick buck' company. 15 years in the making and some of the best Board and scientists in the UK. This is an investment in a breakthrough drug by a small biotech. Open successful results, funding, preorders etc this will no longer be a portacabin company but a large global player. That's if a big shark doesn't eat us up very soon after results.
Thanks Monticello. There has been no delay of p3 news either. As RM says “data is king” and the 90 day long covid data only completed yesterday. It would have add our 90 day data invalid if we released the results before the data was collected. It’s only our impatience that has lead to the frustration around the time it has taken.
The team at SNG have moved mountains to get a p2 and worldwide P3 completed in 2 years. In normal times that would take over 5 years. We are not Pfizer or AZ so we were up against all the big boys trying to fill our trial, when they were also trialling their drugs. But they have done it and that’s no mean feat. We are potentially just days away from our P3 readout and a potential breakthrough anti viral drug that could be in every hospital around the world within the next year. Yes America will be first but the new recruits for Europe today shows that we are not ignoring closer to home too. There’s a big market out there and the team that RM is building will be capable of selling to every government and healthcare system around the world. Not forgetting the potential for stockpiling for future pandemics.
Ignore the white noise of some posters and prepare yourself for a once in a lifetime opportunity and life changing returns if all comes to fruition.
Good luck and don’t let them take your shares off you too cheap!
To say that Rm doesn’t care about the SP is way off the mark. Yes not their primary driver but one that allows them to make certain decisions around a further placing to ramp up production etc. we will need cash and I expect the only guarantee they can plan for is to raise on the markets. If it comes via BARDA or JV with pharma Co great but they will plan for certain scenarios. My best guess and that’s all it is (anyone who says otherwise is an idiot) would be middle of jan. I’ve had confirmation that an interview has been lined up with proactive Tv and RM in ‘January’ so that’s all we have to go by. And ‘early 22’ from the boss’s mouth.
Agreed Andy, we could yet see the Uk Government/MRHA react quickly after our results are out. They've been quiet but actually if you take away Activ2 in the US, everyones been quiet over SNG! If they all want SNG001 to help with this wave of infections they will need to move mountains, but we know they can (if it suits their agenda).
Yeah i'm really not happy with that title. Just the word 'Subcutaneous' before it would have been fine. But to generalify that 'Interferon' failed is a disgrace, especially considering they are funding the Activ2 trial with another interferon subject. Clarification is needed.